Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US Stock MarketDetailed Quotes
AQST Aquestive Therapeutics
- 2.830
- -0.170-5.67%
Close May 5 16:00 ET
279.81MMarket Cap-5.55P/E (TTM)
3.005High2.820Low806.38KVolume2.970Open3.000Pre Close2.32MTurnover0.87%Turnover RatioLossP/E (Static)98.87MShares5.80052wk High-4.65P/B263.53MFloat Cap2.20052wk Low--Dividend TTM93.12MShs Float20.696Historical High--Div YieldTTM6.17%Amplitude0.618Historical Low2.872Avg Price1Lot Size
About Aquestive Therapeutics Company
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Company Profile
SymbolAQST
Company NameAquestive Therapeutics
Listing DateJul 25, 2018
Issue Price15.00
Founded2004
CEOMr. Daniel Barber
MarketNASDAQ
Employees142
Fiscal Year Ends12-31
Address30 Technology Drive
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-941-1900
Websitehttp://www.aquestive.com
Company Executives
- Name
- Position
- Salary
- Daniel Barber
- Chief Executive Officer, President and Director
- 4.18M
- Lori J. Braender
- Senior Vice President, General Counsel, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
- 1.82M
- Cassie Jung
- Chief Operating Officer
- --
- A. Ernest Toth, Jr
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Carl N. Kraus, M.D.
- Chief Medical Officer
- --
- Sherry Korczynski
- Senior Vice President, Sales and Marketing
- --
- Peter Boyd
- Senior Vice President, Information Technology, Human Resources and Communications
- --
- Dr. Melina T. Cioffi, Pharm.D.
- Senior Vice President, Regulatory Affairs
- --
- John S. Cochran
- Vice Chairman of the Board
- 156.61K
- Dr. Gregory B. Brown,M.D.
- Chairman of the Board
- 198.50K
- Abigail L. Jenkins, B.A.,M.S.
- Independent Director
- 190.23K
- Timothy E. Morris
- Independent Director
- 170.14K
- Dr. Marco Taglietti,M.D.
- Independent Director
- 147.26K
- Dr. Julie Krop, M.D.
- Independent Director
- 167.34K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now